The National Law Journal


Fish & Richardson was all over the map last year, with appearances in 222 new patent cases in federal courts across the United States, plus a major U.S. Supreme Court win and successful litigation at the International Trade Commission (ITC). The firm also scored two key victories in cases involving the Hatch-Waxman Act, the federal law governing the procedure for bringing generic drugs to market.

This premium content is reserved for National Law Journal subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202551376102

Thank you!

This article's comments will be reviewed.